Literature DB >> 16868710

Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient.

A N Aravindan1, Venkatesh Moger, Vinay Sakhuja, Harbir S Kohli, Neelam Varma, Vivekanand Jha.   

Abstract

Posttransplant lymphoproliferative disorders (PTLD) are commonly caused by Ebstein-Barr Virus infection. The role of hepatitis C virus (HCV) in the genesis of lymphomas has been recognized recently. We report a HCV infected renal transplant recipient who developed PTLD 11 months after transplantation. Reduction of immunosuppression led to disappearance of viremia and clearance of PTLD. This is the first such report in the world literature.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16868710     DOI： 10.1007/s11255-006-0050-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  10 in total

1.  Viruses and lymphomas.

Authors:  Joseph S Pagano
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

2.  Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma.

Authors:  E Zuckerman; T Zuckerman; A M Levine; D Douer; K Gutekunst; M Mizokami; D G Qian; M Velankar; B N Nathwani; T L Fong
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

3.  B cell malignancy and hepatitis C virus infection.

Authors:  T Izumi; R Sasaki; S Tsunoda; M Akutsu; H Okamoto; Y Miura
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

4.  The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection.

Authors:  E Zuckerman; T Zuckerman; D Sahar; S Streichman; D Attias; E Sabo; D Yeshurun; J M Rowe
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

5.  Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients.

Authors:  Christophe Duvoux; Georges-Philippe Pageaux; Claire Vanlemmens; Françoise Roudot-Thoraval; Anne-Laure Vincens-Rolland; Christophe Hézode; Philippe Gaulard; Jean-Philippe Miguet; Dominique Larrey; Daniel Dhumeaux; Daniel Cherqui
Journal:  Transplantation       Date:  2002-10-27       Impact factor: 4.939

6.  Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.

Authors:  K McLaughlin; S Wajstaub; P Marotta; P Adams; D R Grant; W J Wall; A M Jevnikar; K S Rizkalla
Journal:  Liver Transpl       Date:  2000-09       Impact factor: 5.799

7.  Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection.

Authors:  A Buda; A Caforio; F Calabrese; S Fagiuoli; S Pevere; U Livi; R Naccarato; P Burra
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

8.  Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

Authors:  C Hézode; C Duvoux; G Germanidis; F Roudot-Thoraval; A L Vincens; P Gaulard; D Cherqui; J M Pawlotsky; D Dhumeaux
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

9.  Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.

Authors:  F Silvestri; G Barillari; R Fanin; F Salmaso; C Pipan; E Falasca; F Puglisi; L Mariuzzi; F Zaja; L Infanti; F Patriarca; A Candoni; A Rogato; C Di Loreto; G A Botta; M Baccarani
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

10.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

Authors:  Olivier Hermine; François Lefrère; Jean-Pierre Bronowicki; Xavier Mariette; Katayoun Jondeau; Virginie Eclache-Saudreau; Béatrice Delmas; Françoise Valensi; Patrice Cacoub; Christian Brechot; Bruno Varet; Xavier Troussard
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245
  10 in total
  2 in total

1.  Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection.

Authors:  Mikiko Kobayashi; Naoko Asano; Mana Fukushima; Takayuki Honda
Journal:  Int J Hematol       Date:  2014-05-31       Impact factor: 2.490

Review 2.  Hepatitis C and kidney disease: A narrative review.

Authors:  Rashad S Barsoum; Emad A William; Soha S Khalil
Journal:  J Adv Res       Date:  2016-07-26       Impact factor: 10.479
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.